An intronic variant in PTEN is not associated with prostate cancer risk

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):277-8.

Authors

K L Nathanson¹, R Omaruddin, S B Malkowicz, T R Rebbeck

Affiliation

¹ Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6021, USA.

PMID: 11303600

No abstract available

Publication types

Comparative Study

MeSH terms

Age Distribution
Aged
Biomarkers, Tumor / analysis*
Case-Control Studies
Cohort Studies
Humans
Male
Middle Aged
Mutation
Odds Ratio
PTEN Phosphohydrolase
Phosphoric Monoester Hydrolases / analysis
Phosphoric Monoester Hydrolases / genetics*
Polymorphism, Genetic*
Prevalence
Prognosis
Prostatic Neoplasms / epidemiology*
Prostatic Neoplasms / genetics*
Reference Values
Risk Assessment
Sensitivity and Specificity
Tumor Suppressor Proteins*

Substances

Biomarkers, Tumor
Tumor Suppressor Proteins
Phosphoric Monoester Hydrolases
PTEN Phosphohydrolase
PTEN protein, human